Review
doi: 10.1046/j.1463-1326.2002.00189.x.
Efficacy, effectiveness and safety of sulphonylurea-metformin combination therapy in patients with type 2 diabetes
Affiliations
- PMID: 12190992
- DOI: 10.1046/j.1463-1326.2002.00189.x
Item in Clipboard
Review
Efficacy, effectiveness and safety of sulphonylurea-metformin combination therapy in patients with type 2 diabetes
Diabetes Obes Metab.
2002 Sep.
No abstract available
Similar articles
-
The UK Prospective Diabetes Study.Lancet. 1998 Dec 12;352(9144):1932-3; author reply 1934. doi: 10.1016/S0140-6736(05)60422-9. Lancet. 1998. PMID: 9863807 No abstract available.
-
The UK Prospective Diabetes Study.Lancet. 1998 Dec 12;352(9144):1932; author reply 1934. doi: 10.1016/S0140-6736(98)00090-7. Lancet. 1998. PMID: 9863806 No abstract available.
-
Efffect of addition of low-dose rosiglitazone to sulphonylurea therapy on glycemic control in type 2 diabetic patients.Chin Med J (Engl). 2003 May;116(5):785-7. Chin Med J (Engl). 2003. PMID: 12875702 Clinical Trial.
-
[Oral add-on therapy to metformin in type 2 diabetes mellitus: a direct comparison beween canagliflozin and glimepiride].Dtsch Med Wochenschr. 2014 Feb;139 Suppl 2:S65-9. doi: 10.1055/s-0033-1359993. Epub 2014 Jan 30. Dtsch Med Wochenschr. 2014. PMID: 24481635 Review. German. No abstract available.
-
[Metformin--its regimen and effects].Nihon Rinsho. 2002 Sep;60 Suppl 9:382-8. Nihon Rinsho. 2002. PMID: 12387022 Review. Japanese. No abstract available.
Cited by
-
Interactions between antidiabetic drugs and herbs: an overview of mechanisms of action and clinical implications.Diabetol Metab Syndr. 2017 Jul 26;9:59. doi: 10.1186/s13098-017-0254-9. eCollection 2017. Diabetol Metab Syndr. 2017. PMID: 28770011 Free PMC article. Review.
-
Oral antidiabetic agents: current role in type 2 diabetes mellitus.Drugs. 2005;65(3):385-411. doi: 10.2165/00003495-200565030-00005. Drugs. 2005. PMID: 15669880 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
